至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

J. Allergy Clin. Immunol.. 2015-05; 
Focke-TejklMargarete,WeberMilena,NiespodzianaKatarzyna,NeubauerAngela,HuberHans,HenningRainer,StegfellnerGottfried,MadereggerBernhard,HauerMartina,StolzFrank,NiederbergerVerena,MarthKatharina,Eckl-DornaJulia,WeissRichard,ThalhamerJosef,BlattKatharina,ValentPeter,ValentaRu
Products/Services Used Details Operation
Plasmid DNA Preparation … Codon-optimized DNAs encoding fusion proteins consisting of allergen-derived peptides fused to the N- and C-terminus of PreS and containing a C-terminal hexahistidine tag were synthesized (GenScript, Piscataway, NJ) and inserted into the NdeI/XhoI sites of plasmid pET … Get A Quote

摘要

Grass pollen is one of the most important sources of respiratory allergies worldwide.

关键词

Grass pollen allergy,allergen,allergen-specific immunotherapy,peptide-carrier technology,recombinant allergen,recombinant hypoallergenic allergen deriva